Exploring the pathogenesis, biomarkers, and potential drugs for type 2 diabetes mellitus and acute pancreatitis through a comprehensive bioinformatic analysis

Exploring the pathogenesis, biomarkers, and potential drugs for type 2 diabetes mellitus and acute pancreatitis through a comprehensive bioinformatic analysis

BackgroundType 2 diabetes mellitus (T2DM) is a chronic metabolic disease that accounts for > 90% of all diabetes cases. Acute pancreatitis (AP) can be triggered by various factors and is a potentially life-threatening condition. Although T2DM has been shown to have a close relationship with A...

Full description

Saved in:

Bibliographic Details
Main Authors:	Lei Zhong, Xi Yang, Yuxuan Shang, Yao Yang, Junchen Li, Shuo Liu, Yunshu Zhang, Jifeng Liu, Xingchi Jiang
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2024-11-01
Series:	Frontiers in Endocrinology
Subjects:	acute pancreatitis type 2 diabetes mellitus molecular docking machine learning biomarker
Online Access:	https://www.frontiersin.org/articles/10.3389/fendo.2024.1405726/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Pancreatic cystic lesions in diabetes mellitus patients
by: Martyna Rozek, et al.
Published: (2020-06-01)

A large-scale proteomics resource of circulating extracellular vesicles for biomarker discovery in pancreatic cancer
by: Bruno Bockorny, et al.
Published: (2024-12-01)

Diabetic Ketoacidosis Without Diabetes Mellitus in Acute Pancreatitis
by: Duha Zaffar, MD, et al.
Published: (2024-11-01)

Integrative bioinformatics analysis to decipher common pathogenic processes in type 2 diabetes mellitus and pancreatic cancer
by: Faez Falah Alshehri
Published: (2024-12-01)

Multi-omic biomarker panel in pancreatic cyst fluid and serum predicts patients at a high risk of pancreatic cancer development
by: Laura E. Kane, et al.
Published: (2025-01-01)

Integrative bioinformatic approach reveals novel melatonin-related biomarkers for Alzheimer’s disease
by: Hua-xiong Zhang, et al.
Published: (2025-02-01)

Pancreatic Morphology, Immunology, and the Pathogenesis of Acute Pancreatitis
by: Tudorel Mihoc, et al.
Published: (2024-11-01)

NIPAL1 as a prognostic biomarker associated with pancreatic adenocarcinoma progression and immune infiltration
by: Youlong Zhu, et al.
Published: (2025-01-01)

Editorial: Diagnosis and management of acute, chronic, and autoimmune pancreatitis
by: Ravi Kumar Sharma, et al.
Published: (2024-11-01)

Identification of PSMD2 as a promising biomarker for pancreatic cancer patients based on comprehensive bioinformatics and in vitro studies
by: Xiuxue Feng, et al.
Published: (2024-11-01)

Persistent chronic calcific pancreatitis with intraductal calculi associated with secondary diabetes mellitus type 3 and diabetic ketoacidosis – A case report
by: Bahl Gurusha, et al.
Published: (2024-01-01)

Multifunctional exosome-driven pancreatic cancer diagnostics and therapeutics
by: Sitong Zhang, et al.
Published: (2023-12-01)

Identification and validation of a novel autoantibody biomarker panel for differential diagnosis of pancreatic ductal adenocarcinoma
by: Metoboroghene O. Mowoe, et al.
Published: (2025-01-01)

Pancreatic lipase inhibitory activity of selected pharmaceutical agents
by: Hamdan Imad I., et al.
Published: (2019-03-01)

The Past, Present, and Future of Biomarkers for the Early Diagnosis of Pancreatic Cancer
by: Federica Vitale, et al.
Published: (2024-12-01)

Serum matrix metalloproteinase‐7, Syndecan‐1, and CA 19‐9 as a biomarker panel for diagnosis of pancreatic ductal adenocarcinoma
by: Doron Yablecovitch, et al.
Published: (2024-09-01)

BIOMARKERS, NEOANGIOGENESIS AND GROWTH FACTORS IN PANCREATIC CANCER
by: E. M. Frantsiyants, et al.
Published: (2019-09-01)

Mitochondrial uncoupling protein 2: a central player in pancreatic disease pathophysiology
by: Kunpeng Wang, et al.
Published: (2024-12-01)

Elucidating the mechanism of stigmasterol in acute pancreatitis treatment: insights from network pharmacology and in vitro/in vivo experiments
by: Xuanlin Zhao, et al.
Published: (2024-12-01)

Evaluation of the clinical usefulness of pancreatic alpha amylase as a novel biomarker in dogs with acute pancreatitis: a pilot study
by: Keon Kim, et al.
Published: (2024-12-01)

Relationships between diabetes distress and biomarkers in people with type 1 diabetes mellitus
by: V.I. Pankiv, et al.
Published: (2024-12-01)

Novel serum biomarkers for early diagnosis of gestational diabetes mellitus—a review
by: Michał Kunicki, et al.
Published: (2025-12-01)

Deep Multiple Instance Learning Model to Predict Outcome of Pancreatic Cancer Following Surgery
by: Caroline Truntzer, et al.
Published: (2024-12-01)

Impact of Order Set on Exocrine Pancreatic Insufficiency in Chronic Pancreatitis, Pancreatic Cancer, and Pancreatic Resection
by: Michael Ladna, et al.
Published: (2025-01-01)

Pathomic and bioinformatics analysis of clinical-pathological and genomic factors for pancreatic cancer prognosis
by: Yang Li, et al.
Published: (2024-11-01)

Network Toxicology and Molecular Docking Analysis of Tetracycline-Induced Acute Pancreatitis: Unveiling Core Mechanisms and Targets
by: Hang Lei, et al.
Published: (2024-12-01)

Effect of Sechium edule extract on blood sugar levels and pancreatic histopathology in male Rats with type II diabetes mellitus
by: Marti Silfia, et al.
Published: (2024-12-01)

Inhibition Mechanism of Pleurotus citrinipileatus Sing. Ergothioneine on Pancreatic Lipase Activity
by: Zhangchen XIA, et al.
Published: (2025-02-01)

Gene Expression Profiling of Pancreatic Ductal Adenocarcinoma Arising From Intraductal Papillary Mucinous Neoplasms of the Pancreas
by: William A. Ziaziaris, et al.
Published: (2024-12-01)

Clinical Guidelines of the Russian Society of Surgeons, the Russian Gastroenterological Association, the Association of Surgeons-Hepatologists and the Endoscopic Society “REndO” on Diagnostics and Treatment of Chronic Pancreatitis
by: V. T. Ivashkin, et al.
Published: (2022-08-01)

The hidden impact: social isolation and inflammation’s role in pancreatic cancer risk among those with diabetes
by: Lilu Ding, et al.
Published: (2025-01-01)

An exploratory study of serum creatine kinase as a prognostic marker for patients with resectable pancreatic cancer: looking into the relationship with body composition
by: Cong Chen, et al.
Published: (2025-02-01)

Acute pancreatitis as a risk factor of chronic pancreatitis and pancreatic cancer. An overview
by: David Solil, et al.
Published: (2024-11-01)

Patients with Type 2 Diabetes Mellitus Accompanied by Elevated Serum CA19-9 Associated Not with Pancreatic Cancer but Interstitial Lung Disease
by: Shuichi Okada, et al.
Published: (2022-05-01)

Identification and validation the predictive biomarkers based on risk-adjusted control chart in gemcitabine with or without erlotinib for pancreatic cancer therapy
by: Aijun Zhao, et al.
Published: (2024-12-01)

Bioinformatic analysis of ferroptosis related biomarkers and potential therapeutic targets in vitiligo
by: Linli Liu, et al.
Published: (2025-01-01)

Identification and Validation of Senescence-Related Signature by Combining Single Cell and Bulk Transcriptome Data Analysis to Predict the Prognosis and Identify the Key Gene CAV1 in Pancreatic Cancer
by: Chen L, et al.
Published: (2024-11-01)

Identification of biomarkers for the diagnosis of type 2 diabetes mellitus with metabolic associated fatty liver disease by bioinformatics analysis and experimental validation
by: Guiling Wu, et al.
Published: (2025-01-01)

Neonatal diabetes mellitus – manifestation of GATA-6 syndrome
by: Galina Gorbunov, et al.
Published: (2024-09-01)

Development of an interpretable machine learning model based on CT radiomics for the prediction of post acute pancreatitis diabetes mellitus
by: Xiyao Wan, et al.
Published: (2025-01-01)